Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
The purpose of this study is to explore the influence of neoadjuvant chemotherapy in the long term quality of life with advanced gastric cancer patients.
QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy
DRUG: Neoadjuvant Chemotherapy
Quality of life index, The change of quality of life index during the 2 years after surgery., 2 years
Preoperative adjuvant chemotherapy combined with postoperative adjuvant therapy mode was included in the 2018 version of the National Comprehensive Cancer Network (NCCN) guideline as an optional treatment (category 2B) for prospective resectable advanced gastric cancer cases (â‰¥cT2, any N).At home and abroad, the research on neoadjuvant chemotherapy for advanced gastric cancer mainly focuses on the safety and long-term survival, and there are few studies on the quality of life. This study, according to EORTC QLQ-C30 and QLQ-STO22 assessment scale, explores the long term effect of neoadjuvant chemotherapy on the quality of life in patients with advanced gastric cancer.